As previously reported, T cell inflamed score is associated with immunotherapy response; therefore, the relation between EPHB6 expression and T cell inflamed score was evaluated, demonstrating that EPHB6 expression had a remarkably negative correlation with pan-cancer T cell inflamed score (R = -0.31, p<0.0001; Figure 3E). Here, EPHB6 is linked to cancer.